Shou‐Mei Wang
-
- MicroRNA in disease regulation 3
-
- Genomics and Chromatin Dynamics 3
- Melanoma and MAPK Pathways 2
- RNA modifications and cancer 2
-
- Cancer Mechanisms and Therapy 5
-
- Flavonoids in Medical Research 3
-
- Pleural and Pulmonary Diseases 2
-
- Peptidase Inhibition and Analysis 2
- Partner nations
- China
In The Last Decade
Shou‐Mei Wang
16 papers receiving 408 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 135
- Molecular Biology 294
- Applied Microbiology and Biotechnology 8
- Cell Biology 53
- Pathology and Forensic Medicine 52
Countries citing papers authored by Shou‐Mei Wang
This map shows the geographic impact of Shou‐Mei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shou‐Mei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shou‐Mei Wang more than expected).
Fields of papers citing papers by Shou‐Mei Wang
This network shows the impact of papers produced by Shou‐Mei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shou‐Mei Wang. The network helps show where Shou‐Mei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shou‐Mei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 28 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 38 | |
| 7 | 2021 | 16 | |
| 8 | 2018 | 43 | |
| 9 | 2016 | 26 | |
| 10 | 2015 | 14 | |
| 11 | 2015 | 38 | |
| 12 | 2014 | 21 | |
| 13 | 2014 | 34 | |
| 14 | 2013 | 7 | |
| 15 | 2012 | 88 | |
| 16 | 2012 | 41 |
About Shou‐Mei Wang
Shou‐Mei Wang is a scholar working on Applied Microbiology and Biotechnology, Pathology and Forensic Medicine and Cancer Research, having authored 16 papers that have together received 415 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (5 papers), MicroRNA in disease regulation (3 papers), Flavonoids in Medical Research (3 papers), Genomics and Chromatin Dynamics (3 papers), Pleural and Pulmonary Diseases (2 papers), Melanoma and MAPK Pathways (2 papers), RNA modifications and cancer (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (135 citations), Molecular Biology (294 citations) and Applied Microbiology and Biotechnology (8 citations). Shou‐Mei Wang has collaborated with scholars based in China. Frequent co-authors include Xiaojun Feng, Shuhui Zhang, Shu‐Hui Zhang, Ming-hua Zhu, Qing Wu, Peiwei Yang, Xue Huang, Jie Fu, Qing Pan and Shu‐Hui Zhang. Their work appears in journals such as Journal of Ethnopharmacology, Frontiers in Oncology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.